Biofidelity: Matt Franklin

Nov 18, 2022

Genomic technology company Biofidelity has appointed Matt Franklin as a non-executive director. Franklin I currently president and chief operating officer of Akili. He has previously served as the general manager of the oncology business at Exact Sciences, and has held senior leadership roles at Foundation Medicine (acquired by Roche), ArcherDx (acquired by Invitae), and Thrive Earlier Detection (acquired by Exact Sciences).

Breaking News

Biofidelity: Matt Franklin

Cerebral Palsy Sequencing Study Finds Clinically Actionable Alterations

Lucid Diagnostics Raises $22M in Convertible Debt Refinancing

Medicover Genetics Receives IVDR Certification for Genetic Testing Reagent Kit

Final FDA Guidance Lays Path for Drugmakers to Establish Circulating Tumor DNA as Trial Endpoint

Multi-Ancestry Study Uncovers Genetic Contributors to Progressive Eye Disease